GLP-1 medications such as Wegovy, Ozempic, and Zepbound have become increasingly popular for treating obesity and Type 2 diabetes, but insurance coverage for these medications remains inconsistent and financially challenging for consumers who have resorted to getting their GLP1s through other avenues
Patients had a mean age of 58 years and 50% were men
We customize our weight management programs to suit each patients needs providing access to medications, nutritional counseling, strategies to preserve lean muscle mass, assessments of gut health, and exploration of potential hormone-related factors influencing chronic weight issues
GLP-1 receptor agonists are a class of medications that mimic the effects of GLP-1, leading to several benefits including weight loss, improved blood sugar control, and potential cardiovascular benefits
Combining the two might theoretically exacerbate digestive symptoms in susceptible individuals, though this has not been systematically studied